Aflac Incorporated

Aflac Incorporated(AFL)の株式分析

$116.520

-0.058 (-0.05%)終値時点

Loading chart…
High
117.590
Open
117.240
VWAP
116.77
Vol
2.74M
Mkt Cap
50.66B
Low
116.190
Amount
319.84M
EV/EBITDA, TTM
14.56

Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.

www.aflac.com

AI analysis of Aflac Incorporated (AFL)

hold

Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.

Analyst Ratings (15)

-4.82% downside
Hold
3 Buy
10 Hold
2 Sell
Current: 116.52
安値
100.00
平均
110.90
高値
125.00

Wells Fargo

2026-08-19

目標株価

$122

Equal Weight

Wolfe Research

2026-08-19

目標株価

$103

Underperform

JPMorgan

2026-08-11

目標株価

$116

Neutral

Keefe Bruyette

2026-08-11

目標株価

$125

Market Perform

Mizuho

2026-08-10

目標株価

$116

Underperform

バリュエーション指標

The current forward P/E ratio for Aflac Incorporated (AFL) is 14.53, compared to its 5-year average forward P/E of 13.25.

Forward P/E

Fair
5Y Average P/E
13.25
Current P/E
14.53
割高
14.99
割安
11.51

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-22.34
Current EV/EBITDA
14.56
割高
60.14
割安
-104.82

Forward P/S

Overvalued
5Y Average P/S
2.75
Current P/S
3.41
割高
3.33
割安
2.18

Alphio AI Price Scenarios for AFL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AFL

$128.92

シナリオ価格

B

Base

Base · 50%AFL

$107.08

シナリオ価格

B

Bear

Bear · 25%AFL

$100.33

シナリオ価格

Whales holding AFL

T

Turtle Creek Management, LLC

+ HoldingAFL

+18.57%

3M Return

S

Synovus Trust Company, National Association

+ HoldingAFL

+6.47%

3M Return

S

S & Co., Inc.

+ HoldingAFL

+5.38%

3M Return

W

Waters, Parkerson & Co., LLC

+ HoldingAFL

+5.26%

3M Return

D

Destination Wealth Management

+ HoldingAFL

+3.27%

3M Return

S

Sterling Capital Management LLC

+ HoldingAFL

+1.42%

3M Return

AFL FAQ — answered by Alphio AI

Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.

15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める